This page shows the latest Unlicensed Avastin news and features for those working in and with pharma, biotech and healthcare.
of rows over unlicensed use of Avastin in AMD. ... Switching to off-licence Avastin would save £100m or more, if applied across the whole of England.
A group of NHS organisations have claimed a legal victory against Bayer and Novartis, which had sought to stop them using Avastin as a cheap, unlicensed substitute for their ophthalmology drugs. ... The case could not only open the door for more
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...